The evaluation of the consistency of generic drugs has entered normal and 123 varieties have been reviewed

　　Medicine Network November 28 - Chen Shifei, deputy director of China's State Drug Administration, said in Beijing on the 27th that the evaluation of the consistency of generic drugs has entered the normal, so far, a total of 123 varieties, including 323 product regulations, have been reviewed through the consistency evaluation China's State Council Information Office held a press conference on the same day on "on the centralized procurement and use of drugs as a breakthrough to further deepen the health system reform of a number of policy measures" related to the relevant situation Chen Shifei pointed out at the press conference, in order to ensure that through the consistency of the evaluation of the quality and efficacy of varieties and the original drug consistent, to promote the use of generic drugs, the State Drug Administration has issued more than 10 technical guidelines, 22 batches of reference preparations catalog, a total of 1899 product regulations, and opened a "green channel", the consistency evaluation of generic drugs to achieve compliance with the application
"The evaluation of the consistency of generic drugs has entered the norm Chen Shifei said that so far, a total of 123 varieties, including 323 product rules, have been evaluated through consistency All 25 varieties of centralized procurement and use of drugs organized by the State organization spree in the early stages are all drugs that have passed the conformity evaluation of generic drugs
"The centralized procurement and use of drugs by national organizations and the evaluation of consistency are 'two-way drive' Chen Jinfu, deputy director of China's National Medical Security Administration, explained that, on the one hand, consistent evaluation as a prerequisite for centralized procurement and use of drugs, so that Chinese generic drugs and original drugs can compete with Taiwan, on the other hand, the state organization of centralized procurement of drugs on the use of the winning products, improve the enthusiasm of to participate in consistent evaluation, and strongly promote the evaluation of the consistency of generic drugs Chen Jinfu, of the , said that the centralized procurement and use of drugs organized by the state has become an important measure to deepen medical reform It is beneficial to improve the quality level of clinical drug use in China, purify the ecological environment of the pharmaceutical industry, promote the change of the pattern of the pharmaceutical industry, and promote the reform of medical insurance, medicine and medical institutions to form a linkage
"At present, the pilot scope of centralized procurement and use of nationally organized medicines is being extended to the whole country Wang Hesheng, deputy director of the secretariat of the State Council's Leading Group on Medical Reform and deputy director of the National Health Committee, said that the national public market and multi-party procurement pattern will be built, while improving the quality of medicines and ensuring a stable supply of medicines national organizations to centralize the procurement and use of drugs pilot in 11 cities, 25 drugs, the average price reduction of 52% In September 2019, the pilot was expanded to more than 20 provinces and regions in China (Complete)